Amaurosis fugax as the presenting symptom of metastatic lung adenocarcinoma

Abstract

including visual loss, can occur after treatment for CML, including ponatinib-related ocular ischemia, this should be considered a diagnosis of exclusion in the setting of optic atrophy. Imaging of the spine and serial CSF analysis may disclose CNS leptomeningeal disease and extramedullary CNS blast crisis despite negative brain imaging and normal peripheral blood smear and cell counts in CML.